BIOMAT Database Logo BIOMAT Database Logo

Therapeutic concentrations of indinavir in cerebrospinal fluid of HIV-1-infected patients. 1998

K Brinkman, and F Kroon, and P W Hugen, and D M Burger

UI MeSH Term Description Entries
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D019469 Indinavir A potent and specific HIV protease inhibitor that appears to have good oral bioavailability. Crixivan,Indinavir Sulfate,Indinavir, Sulfate (1:1),L-735 524,L-735,524,MK-639,L 735 524,L 735,524,L735 524,L735,524,MK 639,MK639,Sulfate, Indinavir

Related Publications

K Brinkman, and F Kroon, and P W Hugen, and D M Burger
Indinavir in cerebrospinal fluid of HIV-1-infected patients.
January 1997, Lancet (London, England),
K Brinkman, and F Kroon, and P W Hugen, and D M Burger
Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients.
November 2009, AIDS (London, England),
K Brinkman, and F Kroon, and P W Hugen, and D M Burger
Maraviroc concentrations in cerebrospinal fluid in HIV-infected patients.
December 2010, Journal of acquired immune deficiency syndromes (1999),
K Brinkman, and F Kroon, and P W Hugen, and D M Burger
Increasing cerebrospinal fluid chemokine concentrations despite undetectable cerebrospinal fluid HIV RNA in HIV-1-infected patients receiving antiretroviral therapy.
December 2000, Journal of acquired immune deficiency syndromes (1999),
K Brinkman, and F Kroon, and P W Hugen, and D M Burger
Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals.
April 2009, AIDS research and human retroviruses,
K Brinkman, and F Kroon, and P W Hugen, and D M Burger
Neopterin concentrations in cerebrospinal fluid and serum of individuals infected with HIV-1.
May 1989, AIDS (London, England),
K Brinkman, and F Kroon, and P W Hugen, and D M Burger
Cerebrospinal fluid tau concentrations in HIV infected patients with suspected neurological disease.
December 2000, Sexually transmitted infections,
K Brinkman, and F Kroon, and P W Hugen, and D M Burger
Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir/ritonavir combination.
January 2007, AIDS (London, England),
K Brinkman, and F Kroon, and P W Hugen, and D M Burger
Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients.
December 2000, AIDS (London, England),
K Brinkman, and F Kroon, and P W Hugen, and D M Burger
Raltegravir cerebrospinal fluid concentrations in HIV-1 infection.
September 2009, PloS one,
Copied contents to your clipboard!